CD28 costimulation augments IL-2 secretion of activated lamina propria T cells by increasing mRNA stability without enhancing IL-2 gene transactivation

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6621-6629

  Gonsky, Rivkah ^a   Deem, Richard L ^a   Lee, Doo Han ^b   Chen, Alice ^a   Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Seoul Clinical Laboratories   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD28 ANTIGEN; INTERLEUKIN 2;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CYTOKINE RELEASE; GENE CONTROL; LAMINA PROPRIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; RNA STRUCTURE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD2; ANTIGENS, CD28; HUMANS; INTERLEUKIN-2; INTESTINAL MUCOSA; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MICE; NUCLEAR PROTEINS; PLASMIDS; PROTEIN BINDING; RESPONSE ELEMENTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 0033151995     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Durand, D. B., M. R. Bush, J. G. Morgan, A. Weiss, and G. R. Crabtree. 1987. A 275 basepair fragment at the 5′ end of the interleukin 2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J. Exp. Med. 165:395.
2. Serfling, E., R. Barthelmas, I. Pfeuffer, B. Schenk, S. Zarius, R. Swoboda, F. Mercurio, and M. Karin. 1989. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:465.
3. Efrat, S., S. Pilo, and R. Kaempfer. 1982. Kinetics of induction and molecular size of mRNAs encoding human interleukin-2 and γ-interferon. Nature 297:236.
4. Efrat, S., and R. Kaempfer. 1984. Control of biologically active interleukin 2 messenger RNA formation in induced human lymphocytes. Proc. Natl. Acad. Sci. USA 81:2601.
5. Gerez, L., G. Arad, S. Efrat, M. Ketzinel, and R. Kaempfer. 1995. Post-transcriptional regulation of human interleukin-2 gene expression at processing of precursor transcripts. J. Biol. Chem. 270:19569.
6. Hansen, J. A., P. J. Martin, and R. C. Nowinski. 1980. Monoclonal antibodies identifying a novel T cell antigen and Ia antigens of human lymphocytes. Immunogenetics 10:247.
7. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472.
8. Fraser, J. D., B. A. living, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313.
9. Ghosh, P., T. Tan, N. R. Rice, A. Sica, and H. A. Young. 1993. The interleukin 2 CD28-responsive complex contains at least three members of the NF-κB family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA 90:1696.
10. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκBα is necessary for activation of transcription factor NF-κB. Nature 365:182.
11. Liou, H., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and IκB inhibitor system. Curr. Opin. Cell Biol. 5:477.
12. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shiner, and A. Cerami. 1986. Identification of common nucleotide sequence in the 3′ -untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA 83:1670.
13. Lindsten, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244:339.
14. Sachs, A. B. 1993. Messenger RNA degradation in eukaryotes. Cell 74:413.
15. Pirzer, U. C., G. Schümann, S. Post, M. Betzler, and S. C. Meuer. 1990. Differential responsiveness to CD3-Ti vs. CD2-dependent activation of human intestinal T-lymphocytes. Eur. J. Immunol. 20:2339.
16. Targan, S. R., R. L. Deem, M. Liu, S. Wang, and A. Nel. 1995. Definition of a lamina propria T cell responsive state: enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway. J. Immunol. 154:664.
17. Boirivant, M., I. J. Fuss, C. Fiocchi, J. S. Klein, S. A. Strong, and W. Strober. 1996. Hypoproliferative human lamina propria T cells retain the capacity to secrete lymphokines when stimulated via CD2/CD28 signaling pathway. Proc. Assoc. Am. Physicians 108:55.
18. Mulin, G., Z. R. Maycon, L. Braun-Elwert, R. Cerchia, S. P. James, S. Katz, G. Weissman, M. J. McKinley, and S. E. Fisher. 1996. Inflammatory bowel disease mucosal biopsies have specialized lymphokine mRNA profiles. Inflamm. Bowel Dis. 2:16.
19. Gonsky, R., R. L. Deem, C. C. W. Hughes, and S. R. Targan. 1998. Activation of the CD2 pathway in lamina propria T cells up-regulates functionally active AP-1 binding to the IL-2 promoter, resulting in messenger RNA transcription on IL-2 secretion. J. Immunol. 160:4914.
20. Shanahan, P., M. Brogan, and S. R. Targan. 1987. Human mucosal cytotoxic effector cells. Gastroenterology 92:1951.
21. Gillis, S., M. M. Ferm, O. Winny, and K. A. Smith. 1978. T cell growth factor: parameters of production and quantitative microassay for activity. J. Immunol. 120:2027.
22. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds. 1990. Current Protocols in Molecular Biology, Greene Publishing Associates and Wiley-Interscience, New York, pp. 4.10.1-4.10.8.
23. Hughes, C. C. W., and J. S. Pober. 1996. Transcriplional regulation of the interleukin-2 gene in normal human peripheral blood T cells. J. Biol. Chem. 271:5369.
24. Shapiro, V. S., K. E. Truitt, J. B. Imboden, and A. Weiss. 1997. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell. Biol. 17:4051.
25. Angel, P., M. Imagawa. R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729.
26. Verweij, C. L., M. Geerts, and L. A. Aardon. 1991. Activation of interleukin-2 gene transcription via the T cell surface molecule CD28 is mediated through the NF-κB-like response element. J. Biol. Chem. 266:14179.
27. Fraser, J. D., and A. Weiss. 1992. Regulation of T cell lymphokine gene transcription by the accessory molecule CD28. Mol. Cell. Biol. 12:4357.
28. Fraser, J. D., M. E. Newton, and A. Weiss. 1992. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J. Exp. Med. 175:1131.
29. Finn, P. W., H. He, Y. Wang, Z. Wang, G. Guan, J. Listman, and D. L. Perkins. 1997. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability. J. Immun. 158:4074.
30. Umlauf, S. W., B. Beverly, O. Lantz, and R. H. Schwartz. 1995. Regulation of interleukin 2 gene expression by CD28 costimulation in mouse T cell clones: both nuclear and cyloplasmic RNAs are regulated with complex kinetics. Mol. Cell Biol. 15:3197.
31. Bryan, R. G., Y. Li, J. Lai, M. Van, N. R. Rice, R. R. Rich, and T. Tan. 1994. Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol. Cell. Biol. 14:7933.
32. Civil, A., M. Geerts, I. A. Aarden, and C. L. Verweij. 1992. Evidence for a role of CD28RE as a response element for distinct mitogenic T cell activation signals. Eur. J. Immunol. 22:3041.
33. Beg, A. A., and A. S. Baldwin, Jr. 1993. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064.
34. Shapiro, V. S., M. N. Mollenauer, W. C. Greene, and A. Weiss. 1996. c-Rel regulation of IL-2 gene expression may be mediated through activation of AP-1. J. Eip. Med. 184:1663.
35. Curtiss, V. E., R. Smilde and K. L. McGuire 1996. Requirements for interleukin 2 promoter transactivation by the Tax protein of human T cell leukemia vims type 1. Mol. Cell. Biol. 16:3567.
36. Novak, T. J., P. M. White, and E. V. Rothenberg. 1990. Regulatory anatomy of the murine terminal kinase pathway interleukin-2 gene. Nucleic Acids Res. 18:4523.
37. Wright. S., and J. M. Bishop. 1989. DNA sequences that mediate attenuation of transcription from mouse protooncogene myc. Proc. Natl. Acad. Sci. USA 86:505.
38. Sachs, A. 1993. Messenger RNA degradation in eukaryoles. Cell 74:413.
39. 2-terminal kinase pathway. Science 280: 1945.